Fluorouracil NDC 68001-525

Product information

Brand name (proprietary)

Fluorouracil

Generic name (nonproprietary)

fluorouracil

Active ingredients

Fluorouracil — 50 mg/mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

BluePoint Laboratories

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 210124

Marketing start

Feb 18, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Nucleic Acid Synthesis Inhibitors (Mechanism)

Identifiers

Product ID 68001-525_5c040168-a04b-cbb1-e063-6394a90a93f4SPL ID 5c040168-a04b-cbb1-e063-6394a90a93f4

Pharmacologic class

Nucleoside Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468001052527 followed by a unit qualifier and the quantity Copy

Package 68001-0525-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 210124

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.